Total Results: 16191

Despite Complaints About FDA’s Right-To-Try Approach, Watchdog Says It’s Mostly Doing A Good Job

KHN Morning Briefing

The Government Accountability Office did say the agency could do better at providing clear and transparent information about potential side effects of the experimental drugs. In other pharmaceutical news: the House passed an Food and Drug Administration authorization bill, President Donald Trump considers scaling down a program that makes drugmakers give discounted products to hospitals, and a new method might help shave off development time for drugs.

New CDC Director’s Track Record On Public Health Initiatives Worries Some Advocates

KHN Morning Briefing

Brenda Fitzgerald chose to partner with Coke in an effort to fight obesity, a move that raises some eyebrows. “We hope Dr. Fitzgerald, as head of Centers for Disease Control and Prevention, avoids partnering with Coke on obesity for the same reason she would avoid partnering with the tobacco industry on lung cancer prevention,” said Jim O’Hara of the Center for Science in the Public Interest.

Releasing Patients From The Hospital Is A Judgment Call That Can Go Wrong

KHN Morning Briefing

“Most of the time, it’s very complicated. You’re trying to make an assessment: Is the person going to a home? Is there family? Are they reliable? What was the specific reason they were brought in? Is that likely to occur again?” said Bea Grause, president of the New York statewide hospital and health system association HANYS. Meanwhile what happens when a patient wants to leave but the hospital says no?